Evidence map›Paper›PMID 27530311›Full record

ArticleExpert review of anti-infective therapy2016

Statistical detection of geographic clusters of resistant Escherichia coli in a regional network with WHONET and SaTScan.

Rachel Park, Thomas F O'Brien, Susan S Huang, Meghan A Baker, Deborah S Yokoe, Martin Kulldorff, Craig Barrett, Jamie Swift, John Stelling, Centers for Disease Control and Prevention Epicenters Program

Abstract read
In one paragraph

Article in Expert review of anti-infective therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. [Geographic spatial pattern of digestive system cancers in Yiwu city].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rachel Parka Brigham and Women's Hospital, Department of Medicine , Division of Infectious Diseases , Boston , MA , USA.
Thomas F O'Briena Brigham and Women's Hospital, Department of Medicine , Division of Infectious Diseases , Boston , MA , USA.
Susan S Huangd University of California Irvine School of Medicine , Division of Infectious Diseases and Health Policy Research Institute , Orange , CA , USA.
Meghan A Bakera Brigham and Women's Hospital, Department of Medicine , Division of Infectious Diseases , Boston , MA , USA.
Deborah S Yokoea Brigham and Women's Hospital, Department of Medicine , Division of Infectious Diseases , Boston , MA , USA.
Martin Kulldorffa Brigham and Women's Hospital, Department of Medicine , Division of Infectious Diseases , Boston , MA , USA.
Craig Barrettf Premier, Inc ., Safety Solutions , Charlotte , NC , USA.
Jamie Swiftg Mountain States Health Alliance, Department of Infection Prevention , Johnson City , TN , USA.
John Stellinga Brigham and Women's Hospital, Department of Medicine , Division of Infectious Diseases , Boston , MA , USA.
Centers for Disease Control and Prevention Epicenters Program

Funding

WHONET: Tools for a Global Microbial Sensor NetworkR01GM103525 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI STELLING, JOHN · 2012 to 2016
$1.9M
WHONET for automated real-time multilevel global microbial surveillanceR01RR025040 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI STELLING, JOHN · 2008 to 2011
$1.4M
Integrating the world's microbiology laboratories into a global microbial surveillance systemU01CA207167 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI STELLING, JOHN · 2016 to 2018
$1.3M
NCEZID CDC HHS U54 CK000172NCI NIH HHS U01 CA207167NCRR NIH HHS R01 RR025040NIGMS NIH HHS R01 GM103525
6 · The paper itself

Abstract

backgroundWhile antimicrobial resistance threatens the prevention, treatment, and control of infectious diseases, systematic analysis of routine microbiology laboratory test results worldwide can alert new threats and promote timely response. This study explores statistical algorithms for recognizing geographic clustering of multi-resistant microbes within a healthcare network and monitoring the dissemination of new strains over time.

methodsEscherichia coli antimicrobial susceptibility data from a three-year period stored in WHONET were analyzed across ten facilities in a healthcare network utilizing SaTScan's spatial multinomial model with two models for defining geographic proximity. We explored geographic clustering of multi-resistance phenotypes within the network and changes in clustering over time.

resultsGeographic clustering identified from both latitude/longitude and non-parametric facility groupings geographic models were similar, while the latter was offers greater flexibility and generalizability. Iterative application of the clustering algorithms suggested the possible recognition of the initial appearance of invasive E. coli ST131 in the clinical database of a single hospital and subsequent dissemination to others.

conclusionSystematic analysis of routine antimicrobial resistance susceptibility test results supports the recognition of geographic clustering of microbial phenotypic subpopulations with WHONET and SaTScan, and iterative application of these algorithms can detect the initial appearance in and dissemination across a region prompting early investigation, response, and containment measures.

Indexed as

Drug Resistance, BacterialModels, TheoreticalAlgorithmsAnti-Bacterial AgentsCluster AnalysisCross InfectionCross-Sectional StudiesDisease OutbreaksEscherichia coliEscherichia coli InfectionsGeographyHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsantimicrobial resistanceEscherichia coliEscherichia coli ST131Geographic clusteringoutbreak detectionSaTScanWHONET

Identifiers

PMID27530311
PMCPMC5109973

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.